EYECON EYEDROPS

LIVE

Serial Number

88697296

Owner

Division 5 Labs, Inc.

Attorney

Mark C. Johnson

First Use Date

May 10, 2023

Filing Date

Nov 18, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

EYECON EYEDROPS Trademark

Serial Number: 88697296 • Registration: 7108197

EYECON EYEDROPS is a trademark filed by Division 5 Labs, Inc. on November 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Division 5 Labs, Inc. (4 trademarks)

Sunrise, FL 33325

Entity Type: 03

RIVIERA PHARMA INC. (5 trademarks)

16100 SW MARKET ST.
INDIANTOWN, FL 34956

Entity Type: 03

Legal Representation

Attorney of Record

Mark C. Johnson

1,941 trademarks filed View all →

Trademark Details

Filing Date

November 18, 2019

Registration Date

July 11, 2023

First Use Anywhere

May 10, 2023

First Use in Commerce

May 10, 2023

Published for Opposition

March 31, 2020

Goods & Services

Eye drops; Irrigating solutions for eye use; Medical preparations for the treatment of dry eyes and other eye conditions; Medicated eye washes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 11, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Jul 11, 2023 R.PR

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 14, 2023 ASGN

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 3, 2023 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 2, 2023 CNPR

STATEMENT OF USE PROCESSING COMPLETE

May 31, 2023 SUPC

USE AMENDMENT FILED

May 15, 2023 IUAF

TEAS STATEMENT OF USE RECEIVED

May 15, 2023 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 7, 2022 EXRA

SOU EXTENSION 5 GRANTED

Dec 6, 2022 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 6, 2022 AITU

SOU EXTENSION 5 FILED

Nov 28, 2022 EXT5

SOU TEAS EXTENSION RECEIVED

Nov 28, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 28, 2022 EXRA

SOU EXTENSION 4 GRANTED

May 26, 2022 EX4G

SOU EXTENSION 4 FILED

May 26, 2022 EXT4

SOU TEAS EXTENSION RECEIVED

May 26, 2022 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 14, 2022 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 14, 2022 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 14, 2022 REAP

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 26, 2021 EXRA

SOU EXTENSION 3 GRANTED

Nov 24, 2021 EX3G

SOU EXTENSION 3 FILED

Nov 24, 2021 EXT3

SOU TEAS EXTENSION RECEIVED

Nov 24, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 28, 2021 EXRA

SOU EXTENSION 2 GRANTED

May 26, 2021 EX2G

SOU EXTENSION 2 FILED

May 26, 2021 EXT2

SOU TEAS EXTENSION RECEIVED

May 26, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 27, 2020 EXRA

SOU EXTENSION 1 GRANTED

Nov 25, 2020 EX1G

SOU EXTENSION 1 FILED

Nov 25, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 25, 2020 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 26, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 31, 2020 NPUB

PUBLISHED FOR OPPOSITION

Mar 31, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 11, 2020 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 20, 2020 CNSA

ASSIGNED TO EXAMINER

Feb 20, 2020 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 25, 2019 NWOS

NEW APPLICATION ENTERED

Nov 21, 2019 NWAP

Related Trademarks

More from this Owner

RIVIERA PHARMA

RPI RIVIERA PHARMA INC

EYES ALIVE

More in Same Class